ATR and breast carcinoma: Pan-HDAC inhibitors panobinostat and vorinostat hyperacetylate nuclear HSP90, resulting in proteasomal degradation of DNA repair machinery proteins BRCA1, ATR, and CHK1 in breast cancer cells [9].